M&A Deal Summary |
|
|---|---|
| Date | 2021-11-01 |
| Target | Biosynth |
| Sector | Chemicals |
| Buyer(s) |
KKR
Ampersand Capital Partners |
| Sellers(s) |
Armira
Ampersand Capital Partners |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1976 |
| PE ASSETS | 267.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 408 of 483 |
| Sector (Chemicals) | 5 of 5 |
| Type (Secondary Buyout) | 83 of 107 |
| Country (Switzerland) | 6 of 6 |
| Year (2021) | 40 of 52 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-15 |
OVHcloud
Roubaix, France OVHcloud is an IaaS (Infrastructure as a Service) provider specializing in cloud and internet infrastructure. Since its foundation, the business has grown rapidly to become a major provider of dedicated cloud infrastructure, with more than 250,000 servers in data centers across 19 countries. OVHcloud provides services to over a million customers globally and employs a team of more than 400 dedicated research & development engineers. OVHcloud was founded in 1999 and is based in Roubaix, France. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-03 |
Fortifi
The Woodlands, Texas, United States Fortifi is a manufacturer of handheld automated tools and systems and associated aftermarket parts for the protein and other food processing markets. Fortifi is based in The Woodlands, Texas. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 63 of 84 |
| Sector (Chemicals) | 4 of 4 |
| Type (Secondary Buyout) | 4 of 7 |
| Country (Switzerland) | 1 of 1 |
| Year (2021) | 7 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-20 |
N2 Biomedical
Bedford, Massachusetts, United States N2 Biomedical provides coating and surface treatment development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular, and other healthcare end-markets. N2 Biomedical was founded in 2013 and is based in Bedford, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-15 |
Adaptas Solutions
Palmer, Massachusetts, United States Adaptas Solutions is a strategic OEM supplier for key products and manufacturing services for analytical and laboratory equipment manufacturers. Adaptas’ manufacturing vertical integration strategy allows for rapid to-market product development and best in class costing while delivering high-quality products and services. Adaptas Solutions was established in 1983 and is based in Palmer, Massachusetts. |
Sell | $271M |
Armira is an investment holding focused on direct investments in mid-sized companies throughout Germany, Austria, and Switzerland. Broad areas of interest include business services and technology. Armira is headquartered in Munich, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector (Chemicals) | 1 of 1 |
| Type (Secondary Buyout) | 2 of 2 |
| Country (Switzerland) | 1 of 1 |
| Year (2021) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-09 |
Mehler Vario System
Munchen, Germany M-Sicherheitsbeteiligungen GmbH is a manufacturer of ballistic protective equipment. The product portfolio includes an extensive range of high-quality ballistic protection vests, tactical equipment and clothing as well as ballistic protection solutions for vehicles. M-Sicherheitsbeteiligungen is based in Munchen, Germany. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-15 |
IK Multimedia
Modena, Italy IK Multimedia designs and manufactures apps, software, hardware, and accessory products for music creation and playback on computers and mobile devices. The company has direct operating units in 7 countries: Italy, the United States, the United Kingdom, Japan, Mexico, Brazil, and Hong Kong. Its products are sold in over 120 countries with a network of 15,000 resellers and are used by millions of musicians worldwide. IK Multimedia was formed in 1996 and is based in Modena, Italy. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 46 of 55 |
| Sector (Chemicals) | 3 of 3 |
| Type (Secondary Buyout) | 5 of 6 |
| Country (Switzerland) | 1 of 1 |
| Year (2021) | 5 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-20 |
N2 Biomedical
Bedford, Massachusetts, United States N2 Biomedical provides coating and surface treatment development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular, and other healthcare end-markets. N2 Biomedical was founded in 2013 and is based in Bedford, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-15 |
Adaptas Solutions
Palmer, Massachusetts, United States Adaptas Solutions is a strategic OEM supplier for key products and manufacturing services for analytical and laboratory equipment manufacturers. Adaptas’ manufacturing vertical integration strategy allows for rapid to-market product development and best in class costing while delivering high-quality products and services. Adaptas Solutions was established in 1983 and is based in Palmer, Massachusetts. |
Sell | $271M |
